The Global Acute-Migraine Treatment Industry is poised for an extraordinary leap, with projections indicating a substantial valuation of US$ 8.6 billion by 2032, as unveiled in a comprehensive report by Future Market Insights Inc. The industry is set to experience a robust Compound Annual Growth Rate (CAGR) of 4.9% from 2022 to 2032, signifying unprecedented …